Correlation Between MAIA Biotechnology and Roivant Sciences
Can any of the company-specific risk be diversified away by investing in both MAIA Biotechnology and Roivant Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MAIA Biotechnology and Roivant Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MAIA Biotechnology and Roivant Sciences, you can compare the effects of market volatilities on MAIA Biotechnology and Roivant Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MAIA Biotechnology with a short position of Roivant Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of MAIA Biotechnology and Roivant Sciences.
Diversification Opportunities for MAIA Biotechnology and Roivant Sciences
-0.58 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between MAIA and Roivant is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding MAIA Biotechnology and Roivant Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Roivant Sciences and MAIA Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MAIA Biotechnology are associated (or correlated) with Roivant Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Roivant Sciences has no effect on the direction of MAIA Biotechnology i.e., MAIA Biotechnology and Roivant Sciences go up and down completely randomly.
Pair Corralation between MAIA Biotechnology and Roivant Sciences
Given the investment horizon of 90 days MAIA Biotechnology is expected to generate 9.21 times less return on investment than Roivant Sciences. But when comparing it to its historical volatility, MAIA Biotechnology is 1.12 times less risky than Roivant Sciences. It trades about 0.01 of its potential returns per unit of risk. Roivant Sciences is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 128.00 in Roivant Sciences on August 25, 2024 and sell it today you would earn a total of 140.00 from holding Roivant Sciences or generate 109.38% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 31.99% |
| Values | Daily Returns |
MAIA Biotechnology vs. Roivant Sciences
Performance |
| Timeline |
| MAIA Biotechnology |
| Roivant Sciences |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
MAIA Biotechnology and Roivant Sciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with MAIA Biotechnology and Roivant Sciences
The main advantage of trading using opposite MAIA Biotechnology and Roivant Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MAIA Biotechnology position performs unexpectedly, Roivant Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Roivant Sciences will offset losses from the drop in Roivant Sciences' long position.| MAIA Biotechnology vs. Lineage Cell Therapeutics | MAIA Biotechnology vs. Armata Pharmaceuticals | MAIA Biotechnology vs. Portage Biotech | MAIA Biotechnology vs. Larimar Therapeutics |
| Roivant Sciences vs. Roivant Sciences | Roivant Sciences vs. Jasper Therapeutics | Roivant Sciences vs. Humacyte | Roivant Sciences vs. Reviva Pharmaceuticals Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
| Transaction History View history of all your transactions and understand their impact on performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |